Mass vaccination needed to protect against future resurgences of COVID-19
The first long-term seroprevalence study of residents in Wuhan, China, has found that 6.9% of people in the city had
Read more
The first long-term seroprevalence study of residents in Wuhan, China, has found that 6.9% of people in the city had
Read moreThe coronavirus disease 2019 (COVID-19) pandemic, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), continues to disrupt global
Read moreA brief report by researchers at the University of Virginia, USA, proposes using an antibody-based treatment with a plug-and-play strategy
Read moreA large team of researchers affiliated with a host of institutions across the U.K. has found that most SARS-CoV-2 variants
Read moreA new SARS-CoV-2 vaccine candidate, developed by giving a key protein’s gene a ride into the body while encased in
Read moreCoronaviruses are a large family of viruses that can infect both animals and humans. First identified in the 1960s, the
Read moreThe currently approved mRNA vaccines from Moderna and Pfizer-BioNTech help create neutralizing antibodies against the severe acute respiratory syndrome (SARS-CoV-2)
Read moreRespiratory viruses such as SARS-CoV-2 (causing COVID-19) can often catalyze an overactive immune response that leads to a life-threatening cycle,
Read moreThe high infectivity and rapid transmissibility of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has called for various
Read moreCaused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, coronavirus disease 2019 (COVID-19) is speculated to be involved in
Read more